FDA Greenlights Butterfly Network's Advanced Handheld Ultrasound Device, Butterfly iQ3

Tuesday, January 09, 2024

Butterfly Network, a digital health company at the forefront of transforming healthcare with its portable, semiconductor-based ultrasound technology and user-intuitive software, has recently obtained FDA clearance for its latest handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3.

This device marks the third iteration of the groundbreaking semiconductor-based single-probe, whole-body ultrasound system. The Butterfly iQ3 introduces a redesigned ergonomic structure and a doubled data processing speed, enhancing image resolution, sensitivity, and penetration.

Additionally, it brings faster 3D capabilities to facilitate novel automated image capture modes: iQ Slice and iQ Fan. With a substantial customer base of over 145,000 individuals benefiting from our chip-based ultrasound technology, the Butterfly iQ3 represents a significant stride forward in revolutionizing healthcare. Physicians from various specialties now commend the overall image quality, considering it comparable to traditional piezoelectric-based handheld devices. The incorporation of new digital features aims to make ultrasound technology more accessible and approachable than ever before.


Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare CNO Summit - USAHealthcare CMO Summit - USAHealthcare CFO, Financial Strategy & Revenue Cycle SummitHealthcare CEO & Executive Strategy Summit